WisdomTree BioRevolution Fund (WDNA)

Assets	$2.59M
Expense Ratio	0.45%
PE Ratio	21.41
Shares Out	130,000
Dividend (ttm)	$0.77
Dividend Yield	3.92%
Ex-Dividend Date	Dec 26, 2025
Payout Frequency	Annual
Payout Ratio	82.92%

Volume	88
Open	19.66
Previous Close	20.01
Day's Range	19.66 - 19.66
52-Week Low	13.31
52-Week High	21.70
Beta	0.98
Holdings	86
Inception Date	Jun 3, 2021

About WDNA

Fund Home Page

The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is issued by WisdomTree.

• Asset Class: Equity
• Category: Health
• Stock Exchange: BATS
• Ticker Symbol: WDNA
• ETF Provider: WisdomTree
• Index Tracked: WisdomTree BioRevolution Index

Top 10 Holdings

30.84% of assets

Name	Symbol	Weight
Twist Bioscience Corporation	TWST	5.61%
Eli Lilly and Company	LLY	4.23%
Moderna, Inc.	MRNA	3.55%
Johnson & Johnson	JNJ	3.18%
United Therapeutics Corporation	UTHR	2.52%
Immunome, Inc.	IMNM	2.46%
10x Genomics, Inc.	TXG	2.38%
Natera, Inc.	NTRA	2.38%
Darling Ingredients Inc.	DAR	2.36%
Corteva, Inc.	CTVA	2.18%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 26, 2025	$0.77052	Dec 30, 2025
Dec 26, 2024	$0.1071	Dec 30, 2024
Dec 22, 2023	$0.135	Dec 28, 2023
Dec 23, 2022	$0.06526	Dec 29, 2022
Dec 27, 2021	$0.02458	Dec 30, 2021

Performance

WDNA had a total return of 36.10% in the past year, including dividends. Since the fund's inception, the average annual return has been -3.30%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Jul 25, 2026

Data Sources Report a data error